Cited by 693Advanced Drug Delivery SystemsRetinal Diseases and TreatmentsOcular Infections and Treatments

The DOI matches its Crossref record; 476 of the 476 references it cites were found in a registry or an index.

Pharmacokinetic aspects of retinal drug delivery

Open access

del Amo, Eva M., Rimpelä, Anna-Kaisa, Heikkinen, Emma, Kari, Otto K., Ramsay, Eva, Lajunen, Tatu, Schmitt, Mechthild, Pelkonen, Laura, Bhattacharya, Madhushree, Richardson, Dominique, Subrizi, Astrid, Turunen, Tiina, Reinisalo, Mika, Itkonen, Jaakko, Toropainen, Elisa, Casteleijn, Marco, Kidron, Heidi, Antopolsky, Maxim, Vellonen, Kati-Sisko, Ruponen, Marika, Urtti, Arto·2017·Progress in Retinal and Eye Research

DOI 10.1016/j.preteyeres.2016.12.001

Open this paper in CoChat — free account Open PDF

Abstract

Drug delivery to the posterior eye segment is an important challenge in ophthalmology, because many diseases affect the retina and choroid leading to impaired vision or blindness. Currently, intravitreal injections are the method of choice to administer drugs to the retina, but this approach is applicable only in selected cases (e.g. anti-VEGF antibodies and soluble receptors). There are two basic approaches that can be adopted to improve retinal drug delivery: prolonged and/or retina targeted delivery of intravitreal drugs and use of other routes of drug administration, such as periocular, suprachoroidal, sub-retinal, systemic, or topical. Properties of the administration route, drug and delivery system determine the efficacy and safety of these approaches. Pharmacokinetic and pharmacodynamic factors determine the required dosing rates and doses that are needed for drug action. In addition, tolerability factors limit the use of many materials in ocular drug delivery. This review article provides a critical discussion of retinal drug delivery, particularly from the pharmacokinetic point of view. This article does not include an extensive review of drug delivery technologies, because they have already been reviewed several times recently. Instead, we aim to provide a systematic and quantitative view on the pharmacokinetic factors in drug delivery to the posterior eye segment. This review is based on the literature and unpublished data from the authors' laboratory.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.preteyeres.2016.12.001

Cites

476 of 476 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.
Boussif, O., Lezoualc’h, F., Zanta, M. A., Djavaheri‐Mergny, M., Scherman, D., DEMENEIX, B. A., & Behr, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,256
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
Wong, W. L., Su, X., Li, X., Cheung, C. M. G., Klein, R., Cheng, C., & Wong, T. Y. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70145-1 · Cited by 5,545
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,958
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Müller cells in the healthy and diseased retina
Bringmann, A., Pannicke, T., Grosche, J., Francke, M., Wiedemann, P., Skatchkov, S. N., Osborne, N. N., & Reichenbach, A. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.05.003 · Cited by 1,967
Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems
Karimi, M., Ghasemi, A., Zangabad, P. S., Rahighi, R., Basri, S. M. M., Mirshekari, H., Amiri, M., Shafaei, Z., Aslani, A., Bozorgomid, M., et al. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00798d · Cited by 1,557
The Major Cell Populations of the Mouse Retina
Jeon, C.-J., Strettoi, E., & Masland, R. H. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-21-08936.1998 · Cited by 1,429
Effects of protein aggregates: An immunologic perspective
Rosenberg, A. S. (2006) · The AAPS Journal · doi:10.1208/aapsj080359 · Cited by 1,355
What the Cell “Sees” in Bionanoscience
Dorota, W., Bombelli, F. B., Monopoli, M. P., Lynch, I., & Dawson, K. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910675v · Cited by 1,188
Stability of Protein Pharmaceuticals: An Update
Manning, M. C., Chou, D. K., Murphy, B. M., Payne, R. W., & Katayama, D. S. (2010) · Pharmaceutical Research · doi:10.1007/s11095-009-0045-6 · Cited by 1,140
Mechanism of DNA Release from Cationic Liposome/DNA Complexes Used in Cell Transfection,
Xu, Y., & Szoka, F. C. (1996) · Biochemistry · doi:10.1021/bi9602019 · Cited by 1,136
Mechanisms of Age-Related Macular Degeneration
Ambati, J., & Fowler, B. J. (2012) · Neuron · doi:10.1016/j.neuron.2012.06.018 · Cited by 1,062
The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles
Xiao, K., Li, Y., Luo, J., Lee, J. S., Xiao, W., Gonik, A. M., Agarwal, R. G., & Lam, K. S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.021 · Cited by 1,039
The Transporter Classification Database (TCDB): recent advances
Saier, M. H., Reddy, V. S., Tsu, B. V., Ahmed, M. S., Li, C., & Moreno‐Hagelsieb, G. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1103 · Cited by 1,010
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003
Self-citation
Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation
Deng, Z. J., Liang, M., Monteiro, M. J., Tóth, I., & Minchin, R. F. (2010) · Nature Nanotechnology · doi:10.1038/nnano.2010.250 · Cited by 893
A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics
Steichen, S. D., Caldorera-Moore, M., & Peppas, N. A. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.12.006 · Cited by 751
Long-Term Effect of Gene Therapy on Leber’s Congenital Amaurosis
Bainbridge, J. W. B., Mehat, M. S., Sundaram, V., Robbie, S. J., Barker, S. E., Ripamonti, C., Georgiadis, A., Mowat, F. M., Beattie, S. G., Gardner, P. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414221 · Cited by 743
Parameters influencing the stealthiness of colloidal drug delivery systems
Vonarbourg, A., Passirani, C., Saulnier, P., & Benoit, J.-P. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.039 · Cited by 740
Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions
Klaassen, I., Noorden, C. J. F. V., & Schlingemann, R. O. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.02.001 · Cited by 738
The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited
Anderson, D. H., Radeke, M. J., Gallo, N. B., Chapin, E. A., Johnson, P. T., Curletti, C. R., Hancox, L. S., Hu, J., Ebright, J. N., Malek, G., et al. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.11.003 · Cited by 727
The nanoparticle biomolecule corona: lessons learned – challenge accepted?
Docter, D., Westmeier, D., Markiewicz, M., Stolte, S., Knauer, S. K., & Stauber, R. H. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00217f · Cited by 719
Proceedings of the International Society for Magnetic Resonance in Medicine
(2018) · Proceedings of the Society of Magnetic Resonance in Medicine · doi:10.1002/(issn)1557-3672 · Cited by 718
Pharmacokinetics of Intravitreal Bevacizumab (Avastin)
Bakri, S. J., Snyder, M. R., Reid, J. M., Pulido, J. S., & Singh, R. J. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.01.017 · Cited by 683
Inflammation and its role in age-related macular degeneration
Kauppinen, A., Paterno, J. J., Błasiak, J., Salminen, A., & Kaarniranta, K. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2147-8 · Cited by 683
Coexistence of passive and carrier-mediated processes in drug transport
Sugano, K., Kansy, M., Artursson, P., Avdeef, A., Bendels, S., Di, L., Ecker, G. F., Faller, B., Fischer, H., Gerebtzoff, G., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3187 · Cited by 672
Rapid translocation of nanoparticles from the lung airspaces to the body
Choi, H. S., Ashitate, Y., Lee, J. H., Kim, S. H., Matsui, A., Insin, N., Bawendi, M. G., Semmler‐Behnke, M., Frangioni, J. V., & Tsuda, A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1696 · Cited by 668
Photobleaching kinetics of fluorescein in quantitative fluorescence microscopy
Song, L., Hennink, E. J., Young, I. T., & Tanke, H. J. (1995) · Biophysical Journal · doi:10.1016/s0006-3495(95)80442-x · Cited by 658
Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle.
Wagner, E., Plank, C., Zatloukal, K., Cotten, M. L., & Birnstiel, M. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.7934 · Cited by 657
Müller glial cell reprogramming and retina regeneration
Goldman, D. J. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3723 · Cited by 652
Permeability of cornea, sclera, and conjunctiva: A literature analysis for drug delivery to the eye
Prausnitz, M. R., & Noonan, J. S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9802594 · Cited by 630
Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
Holz, F. G., Tadayoni, R., Beatty, S., Berger, A. R., Cereda, M. G., Cortez, R. T., Hoyng, C. B., Hykin, P. G., Staurenghi, G., Heldner, S., et al. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-305327 · Cited by 624
Melanosomes — dark organelles enlighten endosomal membrane transport
Raposo, G., & Marks, M. S. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2258 · Cited by 623
Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity
Szebeni, J. (2005) · Toxicology · doi:10.1016/j.tox.2005.07.023 · Cited by 610
Ocular and optic nerve blood flow at normal and increased intraocular pressures in monkeys (Macaca irus): a study with radioactively labelled microspheres including flow determinations in brain and some other tissues
Alm, A., & Bill, A. (1973) · Experimental Eye Research · doi:10.1016/0014-4835(73)90185-1 · Cited by 585
Molecular pathogenesis of retinal and choroidal vascular diseases
Campochiaro, P. A. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.06.002 · Cited by 563
Recent advances in the use of cell-penetrating peptides for medical and biological applications☆
Fonseca, S. B., Pereira, M. P., & Kelley, S. O. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.001 · Cited by 563
Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus
Brunner, S., Sauer, T., Carotta, S., Cotten, M. L., Saltik, M., & Wagner, E. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301102 · Cited by 534
The role of the retinal pigment epithelium: Topographical variation and ageing changes
Boulton, M. E., & Dayhaw‐Barker, P. (2001) · Eye · doi:10.1038/eye.2001.141 · Cited by 525
The Transporter Classification Database
Saier, M. H., Reddy, V. S., Tamang, D. G., & Västermark, Å. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1097 · Cited by 510
Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration
Gaudreault, J., Fei, D., Rusit, J., Suboc, P., & Shiu, V. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0601 · Cited by 501
Melanins and melanogenesis: from pigment cells to human health and technological applications
d’Ischia, M., Wakamatsu, K., Cicoira, F., Mauro, E. D., García-Borrón, J. C., Commo, S., Galván, I., Ghanem, G., Kenzo, K., Meredith, P., et al. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12393 · Cited by 499
Biochemistry of the Eye
Berman, E. R. (1991) · Springer eBooks · doi:10.1007/978-1-4757-9441-0 · Cited by 482
Blood circulation and fluid dynamics in the eye
Bill, A. (1975) · Physiological Reviews · doi:10.1152/physrev.1975.55.3.383 · Cited by 468
Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides
Liu, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.04.006 · Cited by 433
Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention
Szebeni, J., Muggia, F. M., Gabizón, A., & Barenholz, Y. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.017 · Cited by 424
Current and future ophthalmic drug delivery systems
del Amo, E. M., & Urtti, A. O. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.11.002 · Cited by 424
Self-citation
Corneal Penetration Behavior of β-Blocking Agents I: Physicochemical Factors
Huang, H.-S., & Schoenwald, R. D. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600721108 · Cited by 422
Cytokines as biomarkers of nanoparticle immunotoxicity
Elsabahy, M., & Wooley, K. L. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60064e · Cited by 417
Geographic Atrophy
Holz, F. G., Strauss, E. C., Schmitz-Valckenberg, S., & Campagne, M. V. L. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.11.023 · Cited by 404
Microglial Activation in Human Diabetic Retinopathy
Zeng, H.-Y. (2008) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2007.65 · Cited by 401
Topical and systemic drug delivery to the posterior segments
HUGHES, P., OLEJNIK, O., Chang-Lin, J.-E., & WILSON, C. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.004 · Cited by 400
Protein corona significantly reduces active targeting yield
Mirshafiee, V., Mahmoudi, M., Lou, K., Cheng, J., & Kraft, M. L. (2013) · Chemical Communications · doi:10.1039/c3cc37307j · Cited by 395
Subretinal visual implant alpha IMS - clinical trial interim report
Stingl, K., Bartz-Schmidt, K. U., Besch, D., Chee, C. K., Cottriall, C. L., Gekeler, F., Groppe, M., Jackson, T. L., MacLaren, R. E., Koitschev, A., et al. (2015) · Vision Research · doi:10.1016/j.visres.2015.03.001 · Cited by 387
A schematic eye for the mouse, and comparisons with the rat
Remtulla, S., & Hallett, P. E. (1985) · Vision Research · doi:10.1016/0042-6989(85)90076-8 · Cited by 387
Mechanisms of pathogen entry through the endosomal compartments
Grüenberg, J., & van der Goot, F. G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1959 · Cited by 375
Intraocular Pharmacokinetics of Bevacizumab After a Single Intravitreal Injection in Humans
Krohne, T. U., Eter, N., Holz, F. G., & Meyer, C. H. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.05.036 · Cited by 364
Adult vitreous structure and postnatal changes
Goff, M. L., & Bishop, P. N. (2008) · Eye · doi:10.1038/eye.2008.21 · Cited by 364
The Eye: Basic Sciences in Practice
Forrester, J. V., Dick, A. D., McMenamin, P. G., Roberts, F., & Parkinson, M. (2002) · UWA Profiles and Research Repository (UWA) · Cited by 362
Current Understanding of the Binding Sites, Capacity, Affinity, and Biological Significance of Metals in Melanin
Hong, L., & Simon, J. D. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp071439h · Cited by 360
Ocular absorption following topical delivery
Järvinen, K., Järvinen, T., & Urtti, A. O. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00010-5 · Cited by 360
Self-citation
Untitled work
(2000) · PubMed · Cited by 358
Ocular Drug Delivery Targeting the Retina and Retinal Pigment Epithelium Using Polylactide Nanoparticles
Bourges, J., Gautier, S., Delié, F., Bejjani, R. A., Jeanny, J., Gurny, R., BenEzra, D., & Béhar‐Cohen, F. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1068 · Cited by 357
Inner limiting membrane barriers to aav-mediated retinal transduction from the vitreous
Dalkara, D., Kolstad, K. D., Caporale, N., Visel, M., Klimczak, R. R., Schaffer, D. V., & Flannery, J. G. (2009) · Molecular Therapy · doi:10.1038/mt.2009.181 · Cited by 357
Drug transport in corneal epithelium and blood–retina barrier: Emerging role of transporters in ocular pharmacokinetics
Mannermaa, E., Vellonen, K., & Urtti, A. O. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.024 · Cited by 356
Self-citation
Current management of glaucoma
Lusthaus, J., & Goldberg, I. (2019) · Medical Journal of Australia · doi:10.5694/mja2.50020 · Cited by 354
Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies
Ruponen, M., Ylä‐Herttuala, S., & Urtti, A. O. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00199-0 · Cited by 352
Self-citation
Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes
Friend, D. S., Papahadjopoulos, D., & Debs, R. J. (1996) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00219-7 · Cited by 352
Human sclera: Thickness and surface area
Olsen, T. W., Aaberg, S., Geroski, D. H., & Edelhauser, H. F. (1998) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)80096-8 · Cited by 349
The Immunogenicity of Polyethylene Glycol: Facts and Fiction
Schellekens, H., Hennink, W. E., & Brinks, V. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1067-7 · Cited by 344
Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo
Xu, Q., Boylan, N. J., Suk, J. S., Wang, Y.-Y., Nance, E. A., Yang, J., McDonnell, P. J., Cone, R. A., Duh, E. J., & Hanes, J. S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.018 · Cited by 339
Fusion of cationic liposomes with mammalian cells occurs after endocytosis
Wrobel, I., & Collins, D. S. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)80017-a · Cited by 339
Suprachoroidal drug delivery to the back of the eye using hollow microneedles
Patel, S. R., Lin, A. S. P., Edelhauser, H. F., & Prausnitz, M. R. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0271-y · Cited by 330
Differential Roles of the Protein Corona in the Cellular Uptake of Nanoporous Polymer Particles by Monocyte and Macrophage Cell Lines
Yan, Y., Gause, K. T., Kamphuis, M. M. J., Ang, C., O’brien-simpson, N. M., Lenzo, J. C., Reynolds, E. C., Nice, E. C., & Caruso, F. (2013) · ACS Nano · doi:10.1021/nn404481f · Cited by 330
Molecular Nanomedicine Towards Cancer: 111In-Labeled Nanoparticles
Psimadas, D., Georgoulias, P., Valotassiou, V. J., & Loudos, G. K. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23146 · Cited by 322
The structural basis of the blood-ocular barriers
Raviola, G. (1977) · Experimental Eye Research · doi:10.1016/s0014-4835(77)80009-2 · Cited by 320
Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma
Zhang, K., Zhang, L., & Weinreb, R. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3745 · Cited by 320
Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature
Wolking, S., Schaeffeler, E., Lerche, H., Schwab, M. G., & Nies, A. T. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0267-1 · Cited by 313
Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery.
Poste, G. H., Bucana, C. D., Raz, A., Bugelski, P. J., Kirsh, R. L., & Fidler, I. J. (1982) · PubMed · Cited by 309
Importance of the noncorneal absorption route in topical ophthalmic drug delivery.
Ahmed, I., & Patton, T. F. (1985) · PubMed · Cited by 287
Interaction Between Chemicals and Melanin
LARSSON, B. S. (1993) · Pigment Cell Research · doi:10.1111/j.1600-0749.1993.tb00591.x · Cited by 287
Safety assessment of nanomaterials: Implications for nanomedicine
Nyström, A. M., & Fadeel, B. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.027 · Cited by 276
Melanosomes at a glance
Wasmeier, C., Hume, A. N., Bolasco, G., & Seabra, M. C. (2008) · Journal of Cell Science · doi:10.1242/jcs.040667 · Cited by 270
Plasmid DNA entry into postmitotic nuclei of primary rat myotubes.
Dowty, M. E., Williams, P., Zhang, G., Hagstrom, J. E., & Wolff, J. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4572 · Cited by 270
Pharmacokinetics of Bevacizumab after Topical, Subconjunctival, and Intravitreal Administration in Rabbits
Nomoto, H., Shiraga, F., Kuno, N., Kimura, E., Fujii, S., Shinomiya, K., Nugent, A. K., Hirooka, K., & Baba, T. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3148 · Cited by 269
Minimizing systemic absorption of topically administered ophthalmic drugs
Urtti, A. O., & Salminen, L. (1993) · Survey of Ophthalmology · doi:10.1016/0039-6257(93)90141-s · Cited by 267
Self-citation
The organ uptake of intravenously administered colloidal particles can be altered using a non‐ionic surfactant (Poloxamer 338)
Illum, L., & Davis, S. S. (1984) · FEBS Letters · doi:10.1016/0014-5793(84)80836-4 · Cited by 267
Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera.
Hämäläinen, K. M., Kananen, K., Auriola, S. O. K., Kontturi, K., & Urtti, A. O. (1997) · PubMed · Cited by 266
Self-citation
Advances in the chemistry of small molecule fluorescent probes
Wysocki, L. M., & Lavis, L. D. (2011) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2011.10.013 · Cited by 266
Reexamination of the structure of eumelanin
Ito, S. (1986) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(86)90146-7 · Cited by 266
The maximal size of protein to diffuse through the nuclear pore is larger than 60 kDa
Wang, R., & Brattain, M. G. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.05.082 · Cited by 266
Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory
Crist, R. M., Grossman, J. H., Patri, A. K., Stern, S. T., Dobrovolskaia, M. A., Adiseshaiah, P. P., Clogston, J. D., & McNeil, S. E. (2012) · Integrative Biology · doi:10.1039/c2ib20117h · Cited by 266
Loss of melanin from human RPE with aging: possible role of melanin photooxidation
Sarna, T., Burke, J. M., Korytowski, W., Rôżanowska, M., Skumatz, C. M. B., Zaręba, A., & Zaręba, M. (2003) · Experimental Eye Research · doi:10.1016/s0014-4835(02)00247-6 · Cited by 263
Role of Ocular Melanin in Ophthalmic Physiology and Pathology †
Hu, D., Simon, J. D., & Sarna, T. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2008.00316.x · Cited by 261
Permeability of Retinal Pigment Epithelium: Effects of Permeant Molecular Weight and Lipophilicity
Pitka¨nen, L., Ranta, V.-P., Moilanen, H., & Urtti, A. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1051 · Cited by 261
Self-citation
Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression.
Kompella, U., Bandi, N., & Ayalasomayajula, S. (2003) · Investigative Ophthalmology and Visual Science · doi:10.1167/iovs.02-0791 · Cited by 259
Lysosomal localization of β-fructofuranosidase-containing liposomes injected into rats. Some implications in the treatment of genetic disorders
Gregoriadis, G. C., & Ryman, B. E. (1972) · Biochemical Journal · doi:10.1042/bj1290123 · Cited by 258
Penetration of Bevacizumab through the Retina after Intravitreal Injection in the Monkey
Heiduschka, P., Fietz, H., Hofmeister, S., Schultheiss, S., Mack, A. F., Peters, S., Ziemssen, F., Niggemann, B., Julien, S., Bartz‐Schmidt, K. U., et al. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1171 · Cited by 253
Gold nanoparticles enable selective light-induced contents release from liposomes
Paasonen, L., Laaksonen, T., Johans, C., Yliperttula, M. L., Kontturi, K., & Urtti, A. O. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.009 · Cited by 251
Self-citation
Characterization of the Vitreous Proteome in Diabetes without Diabetic Retinopathy and Diabetes with Proliferative Diabetic Retinopathy
Gao, B., Chen, X., Timothy, N. H., Aiello, L. P., & Feener, E. P. (2008) · Journal of Proteome Research · doi:10.1021/pr800112g · Cited by 250
Cellular Uptake, Cytotoxicity, and Innate Immune Response of Silica−Titania Hollow Nanoparticles Based on Size and Surface Functionality
Oh, W., Kim, S., Choi, M., Kim, C., Jeong, Y. S., Cho, B.-R., Hahn, J., & Jang, J. (2010) · ACS Nano · doi:10.1021/nn100561e · Cited by 249
Targeted Administration into the Suprachoroidal Space Using a Microneedle for Drug Delivery to the Posterior Segment of the Eye
Patel, S. R., Berezovsky, D. E., McCarey, B. E., Zarnitsyn, V. G., Edelhauser, H. F., & Prausnitz, M. R. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9872 · Cited by 246
Intraocular Pharmacokinetics of Ranibizumab Following a Single Intravitreal Injection in Humans
Krohne, T. U., Liu, Z., Holz, F. G., & Meyer, C. H. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.03.047 · Cited by 246
Safety evaluation of ocular drug delivery formulations: Techniques and practical considerations
Short, B. G. (2008) · Toxicologic Pathology · doi:10.1177/0192623307310955 · Cited by 244
Neonatal Fc receptor and IgG-based therapeutics
Kuo, T. T., & Aveson, V. G. (2011) · mAbs · doi:10.4161/mabs.3.5.16983 · Cited by 243
Innate immunity in the retina: Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells
Kumar, M. V., Nagineni, C. N., Chin, M. S., Hooks, J. J., & Detrick, B. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.04.018 · Cited by 243
Intracellular Drug Concentrations and Transporters: Measurement, Modeling, and Implications for the Liver
Chu, X., Korzekwa, K., Elsby, R., Fenner, K., Galetin, A., Lai, Y., Matsson, P., Moss, A., Nagar, S., Rosania, G., et al. (2013) · Clinical pharmacology and therapy · doi:10.1038/clpt.2013.78 · Cited by 242
Ocular delivery of macromolecules
Kim, Y. C., Chiang, B., Wu, X., & Prausnitz, M. R. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.043 · Cited by 239
The active transport of fluorescein by the retinal vessels and the retina
Cunha-Vaz, J. G., & Maurice, D. M. (1967) · The Journal of Physiology · doi:10.1113/jphysiol.1967.sp008262 · Cited by 233
Studies on the permeability of the blood-retinal barrier
Shakib, M., & Cunha-Vaz, J. G. (1966) · Experimental Eye Research · doi:10.1016/s0014-4835(66)80011-8 · Cited by 232
Rabbit as an animal model for intravitreal pharmacokinetics: Clinical predictability and quality of the published data
del Amo, E. M., & Urtti, A. O. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.05.003 · Cited by 231
Self-citation
Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning.
Olsen, T. W., Edelhauser, H. F., Lim, J. I., & Geroski, D. H. (1995) · PubMed · Cited by 230
Intracellular Distribution and Mechanism of Delivery of Oligonucleotides Mediated by Cationic Lipids
Zelphati, O., & Szoka, F. C. (1996) · Pharmaceutical Research · doi:10.1023/a:1016026101195 · Cited by 230
Studies on the mechanism of drug-binding to melanin
LARSSON, B. S., & Tjälve, H. (1979) · Biochemical Pharmacology · doi:10.1016/0006-2952(79)90326-5 · Cited by 228
Intravenously administered gold nanoparticles pass through the blood–retinal barrier depending on the particle size, and induce no retinal toxicity
Kim, J. H., Kim, J. H., Kim, K., Kim, M. H., & Yu, Y. S. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/50/505101 · Cited by 228
Blood flow in the normal human retina.
Feke, G. T., Tagawa, H., Deupree, D. M., Goger, D. G., Sebag, J., & Weiter, J. J. (1989) · PubMed · Cited by 225
A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA
Ludtke, J. J., Zhang, G., Sebestyén, M. G., & Wolff, J. A. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.12.2033 · Cited by 220
The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection
Koo, H., Moon, H., Han, H., Na, J. H., Huh, M. S., Park, J. H., Woo, S. J., Park, K. H., Kwon, I. C., Kim, K., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.01.030 · Cited by 218
Results at 2 Years after gene therapy for RPE65-deficient leber congenital amaurosis and severe early-childhood–onset retinal dystrophy
Weleber, R. G., Pennesi, M. E., Wilson, D. J., Kaushal, S., Erker, L. R., Jensen, L., McBride, M. T., Flotte, T. R., Humphries, M., Calcedo, R., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.03.003 · Cited by 218
Lipid-Based Nanocarriers for RNA Delivery
Xue, H. Y., Guo, P., Wen, W., & Wong, H. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150531164540 · Cited by 212
Biodegradable microspheres for vitreoretinal drug delivery
Herrero‐Vanrell, R., & Refojo, M. F. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00200-9 · Cited by 211
Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV
Singh, S. R., GROSSNIKLAUS, H. E., Kang, S. J., Edelhauser, H. F., Ambati, B. K., & Kompella, U. B. (2009) · Gene Therapy · doi:10.1038/gt.2008.185 · Cited by 211
Identification of a Common Non-Apoptotic Cell Death Mechanism in Hereditary Retinal Degeneration
Arango‐González, B., Trifunović, D., Sahaboglu, A., Kranz, K., Michalakis, S., Farinelli, P., Koch, S., Koch, F., Cottet, S., Janssen‐Bienhold, U., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112142 · Cited by 209
Ocular Pharmacokinetics
Maurice, D. M., & Mishima, S. (1984) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-69222-2_2 · Cited by 209
Immunological mechanism underlying the immune response to recombinant human protein therapeutics
Sauerborn, M., Brinks, V., Jiskoot, W., & Schellekens, H. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.11.001 · Cited by 206
CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE
Cohen, S. Y., Mimoun, G., Oubraham, H., Zourdani, A., Malbrel, C., Quéré, S., & Schneider, V. (2012) · Retina · doi:10.1097/iae.0b013e31827b6324 · Cited by 204
The outer limiting membrane (OLM) revisited: clinical implications
Béhar‐Cohen, F. (2010) · Clinical ophthalmology · doi:10.2147/opth.s5901 · Cited by 199
Clinical Ocular Pharmacology
(1989) · Elsevier eBooks · doi:10.1016/c2013-0-06552-8 · Cited by 198
Biomedical foundations of ophthalmology
Duane, T. D., & Jaeger, E. A. (1982) · Harper & Row eBooks · Cited by 193
Immune mechanisms in inflammatory and degenerative eye disease
Perez, V. L., & Caspi, R. R. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.04.003 · Cited by 192
Retinal Microglial Activation and Inflammation Induced by Amadori-Glycated Albumin in a Rat Model of Diabetes
Ibrahim, A. S., El‐Remessy, A. B., Matragoon, S., Zhang, W., Patel, Y. P., Khan, S. H., Al-Gayyar, M. M. H., El‐Shishtawy, M. M., & Liou, G. I. (2011) · Diabetes · doi:10.2337/db10-1160 · Cited by 190
Vitreous: A Barrier to Nonviral Ocular Gene Therapy
Peeters, L., Sanders, N. N., Braeckmans, K., Boussery, K., Van de Voorde, J., De Smedt, S. C., & Demeester, J. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0165 · Cited by 189 · cited 2×
“The mesh size in the bovine vitreous was estimated to be in the range of 500 nm (Peeters et al., 2005; Xu et al., 2013) and even in a non-liquefied state the vitreous is not a tight barrier for diffusion (Turunen, 2016).”
Novel Strategies for Anterior Segment Ocular Drug Delivery
Cholkar, K., Patel, S. P., Vadlapudi, A. D., & Mitra, A. K. (2012) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0200 · Cited by 189
Tolerability and Efficacy of Multiple Escalating Doses of Ranibizumab (Lucentis) for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Heier, J. S., Hantsbarger, G. L., & Shams, N. K. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.01.027 · Cited by 189
Differential expression of the complement regulatory proteins in the human eye.
Bora, N. S., Gobleman, C. L., Atkinson, J. P., Pepose, J. S., & Kaplan, H. J. (1993) · PubMed · Cited by 186
Aldose reductase: new insights for an old enzyme
Ramana, K. V. (2011) · BioMolecular Concepts · doi:10.1515/bmc.2011.002 · Cited by 185
Efficiency of Cytoplasmic Delivery by pH-Sensitive Liposomes to Cells in Culture
Chu, C.-J., Dijkstra, J., Lai, M., Hong, K., & Szoka, F. C. (1990) · Pharmaceutical Research · doi:10.1023/a:1015908831507 · Cited by 184
High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection
Weijtens, O., Feron, E. J., Schoemaker, R. C., Cohen, A. F., Lentjes, E. G. W. M., Romijn, F. P. H. T. M., & van Meurs, J. C. (1999) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)00129-4 · Cited by 184
Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts.
Jiang, L. Q., Jorquera, M., & Streilein, J. W. (1993) · PubMed · Cited by 182
Targeting VEGF in eye neovascularization: What's new?
Amadio, M., Govoni, S. M., & Pascale, A. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.027 · Cited by 180
TACHYPHYLAXIS AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
FOROOGHIAN, F., CUKRAS, C., MEYERLE, C. B., CHEW, E. Y., & WONG, W. T. (2009) · Retina · doi:10.1097/iae.0b013e3181a2c1c3 · Cited by 179
Binding of Drugs to Eye Melanin Is Not Predictive of Ocular Toxicity
Leblanc, B., Jezequel, S. G., Davies, T., Hanton, G. C., & Taradach, C. (1998) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1998.1243 · Cited by 179
Aqueous Humor Dynamics in Mice
Aihara, M., Lindsey, J. D., & Weinreb, R. N. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0504 · Cited by 177
Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina
Kim, H., Robinson, S. B., & Csaky, K. G. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9745-6 · Cited by 174
Identification of lymphatics in the ciliary body of the human eye: A novel “uveolymphatic” outflow pathway
Yücel, Y. H., Johnston, M. G., Ly, T., Patel, M., Drake, B., Gümüş, E., Fraenkl, S. A., Moore, S., Tobbia, D., Armstrong, D., et al. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.08.010 · Cited by 174
Barrier analysis of periocular drug delivery to the posterior segment
Ranta, V., Mannermaa, E., Lummepuro, K., Subrizi, A., Laukkanen, A., Antopolsky, M. L., Murtomäki, L. S., Hornof, M., & Urtti, A. O. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.028 · Cited by 174
Self-citation
The UCSF-FDA TransPortal: A Public Drug Transporter Database
Morrissey, K. M., Wen, C. C., Johns, S. J., Zhang, L., Sm, H., & Giacomini, K. M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.44 · Cited by 173
Managing adverse effects of glaucoma medications
Inoue, K. (2014) · Clinical ophthalmology · doi:10.2147/opth.s44708 · Cited by 172
Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment
Olsen, T. W., Feng, X., Wabner, K., Conston, S. R., Sierra, D. H., Folden, D. V., Smith, M. E., & Cameron, J. D. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.05.045 · Cited by 171
Pore-Forming Peptides Induce Rapid Phospholipid Flip-Flop in Membranes
Fattal, E., Nir, S., Parente, R. A., & Szoka, F. C. (1994) · Biochemistry · doi:10.1021/bi00187a044 · Cited by 171
A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits
Kamei, M., Misono, K., & Lewis, H. (1999) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)00239-1 · Cited by 169
Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review
Reardon, G., Kotak, & Schwartz, G. (2011) · Patient Preference and Adherence · doi:10.2147/ppa.s23780 · Cited by 169
Topical Delivery of Avastin to the Posterior Segment of the Eye In Vivo Using Annexin A5‐associated Liposomes
Davis, B. M., Normando, E. M., Guo, L., Turner, L., Nizari, S., O’Shea, P., Moss, S. E., Somavarapu, S., & Cordeiro, M. F. (2014) · Small · doi:10.1002/smll.201303433 · Cited by 165
Topical Dorzolamide for the Treatment of Cystoid Macular Edema in Patients With Retinitis Pigmentosa
Grover, S., Apushkin, M. A., & Fishman, G. A. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.12.030 · Cited by 165
Paracellular Porosity and Pore Size of the Human Intestinal Epithelium in Tissue and Cell Culture Models
Linnankoski, J., Mäkelä, J. T., Palmgrén, J. J., Mauriala, T., Vedin, C., Ungell, A.-L. B., Lazorova, L., Artursson, P., Urtti, A. O., & Yliperttula, M. L. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21961 · Cited by 164
Self-citation
Induction of necrotic cell death by oxidative stress in retinal pigment epithelial cells
Hanus, J., Zhang, H., Wang, Z., Liu, Q., Zhou, Q., & Wang, S. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.478 · Cited by 163
Polarized Expression of Monocarboxylate Transporters in Human Retinal Pigment Epithelium and ARPE-19 Cells
Philp, N. J., Wang, D., Yoon, H., & Hjelmeland, L. M. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0287 · Cited by 163
Cell-penetrating Peptide for Enhanced Delivery of Nucleic Acids and Drugs to Ocular Tissues Including Retina and Cornea
Johnson, L. N., Cashman, S. M., & Kumar‐Singh, R. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300324 · Cited by 162
Interleukin‐6 functions in autoimmune encephalomyelitis: a study in gene‐targeted mice
Mendel, I., Katz, A., Kozak, N., Ben‐Nun, A., & Revel, M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199805)28:05 · Cited by 161
Transscleral drug delivery to the posterior eye: Prospects of pharmacokinetic modeling
Ranta, V., & Urtti, A. O. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.025 · Cited by 160
Self-citation
Gold-embedded photosensitive liposomes for drug delivery: Triggering mechanism and intracellular release
Paasonen, L., Sipilä, T., Subrizi, A., Laurinmäki, P., Butcher, S. J., Rappolt, M., Yaghmur, A., Urtti, A. O., & Yliperttula, M. L. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.07.095 · Cited by 159
Self-citation
Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals: Recent developments and encouraging results
Hom, R. K., & Katzenellenbogen, J. A. (1997) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(97)00066-8 · Cited by 159
Penetration Routes of Topically Applied Eye Medications
Doane, M. G., Jensen, A. D., & Dohlman, C. H. (1978) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)77735-9 · Cited by 158
Antibody–Drug Conjugate (ADC) Clinical Pipeline: A Review
Sassoon, I., & Blanc, V. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-541-5_1 · Cited by 157
Treatment of Acute Posterior Uveitis in a Porcine Model by Injection of Triamcinolone Acetonide Into the Suprachoroidal Space Using Microneedles
Gilger, B. C., Abarca, E. M., Salmon, J. H., & Patel, S. R. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-11747 · Cited by 157
Melanin concentration in normal human retinal pigment epithelium. Regional variation and age-related reduction.
Schmidt, S. Y., & Peisch, R. D. (1986) · PubMed · Cited by 156
Photoreceptor mosaic: Number and distribution of rods and cones in the rhesus monkey retina
Wikler, K. C., Williams, R. W., & RAKIC, P. T. (1990) · The Journal of Comparative Neurology · doi:10.1002/cne.902970404 · Cited by 156
Blood-derived macrophages infiltrate the retina and activate Muller glial cells under experimental choroidal neovascularization
Caicedo, A., Espinosa‐Heidmann, D. G., Piña, Y., Hernandez, E. P., & Cousins, S. W. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2005.01.013 · Cited by 156
Drug Transporter and Cytochrome P450 mRNA Expression in Human Ocular Barriers: Implications for Ocular Drug Disposition
Zhang, T., Xiang, C. D., Gale, D. C., Carreiro, S. T., Wu, E. Y., & Zhang, E. Y. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021121 · Cited by 156
THE REACTION OF UVEAL PIGMENT IN VITRO WITH POLYCYCLIC COMPOUNDS.
Potts, A. M. (1964) · PubMed · Cited by 150
Intravitreal clearance and volume of distribution of compounds in rabbits: In silico prediction and pharmacokinetic simulations for drug development
del Amo, E. M., Vellonen, K., Kidron, H., & Urtti, A. O. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.01.003 · Cited by 148
Self-citation
Implants for drug delivery to the posterior segment of the eye: A focus on stimuli-responsive and tunable release systems
Yasin, M. N., Svirskis, D. M., Seyfoddin, A., & Rupenthal, I. D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.030 · Cited by 146
Human Retinal Molecular Weight Exclusion Limit and Estimate of Species Variation
Jackson, T. L., Antcliff, R. J., Hillenkamp, J., & Marshall, J. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1027 · Cited by 145
Proteomic analysis of human vitreous humor
Murthy, K. R., Goel, R., Subbannayya, Y., Jacob, H. K., Murthy, P. R., Manda, S. S., Patil, A. H., Sharma, R., Sahasrabuddhe, N. A., Parashar, A., et al. (2014) · Clinical Proteomics · doi:10.1186/1559-0275-11-29 · Cited by 145
Characterization of melanin in human iridal and choroidal melanocytes from eyes with various colored irides
Wakamatsu, K., Hu, D., McCormick, S. A., & Ito, S. (2007) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2007.00415.x · Cited by 144
Microspheres of biodegradable polymers as a drug-delivery system in the vitreous.
Moritera, T., Ogura, Y., Honda, Y., Wada, R., Hyon, S., & Ikada, Y. (1991) · PubMed · Cited by 143
Ranibizumab and Aflibercept: Intraocular Pharmacokinetics and Their Effects on Aqueous VEGF Level in Vitrectomized and Nonvitrectomized Macaque Eyes
Niwa, Y., Kakinoki, M., Sawada, T., Wang, X., & Ohji, M. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17279 · Cited by 143
Zonulae adherentes pore size in the external limiting membrane of the rabbit retina.
Milam, A. H., Saari, J. C., Klock, I. B., & Garwin, G. G. (1985) · PubMed · Cited by 142
Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.
Sohn, J.-H., Kaplan, H. J., Suk, H.-J., Bora, P. S., & Bora, N. S. (2000) · PubMed · Cited by 142
A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide
Robinson, M. R., Lee, S. S., Kim, H., Kim, S., Lutz, R. J., Galbán, C. J., Bungay, P. M., Yuan, P., Wang, N. S., Kim, J., et al. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2005.08.007 · Cited by 142
Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug
Stewart, M. W. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-300654 · Cited by 142
Light induced cytosolic drug delivery from liposomes with gold nanoparticles
Lajunen, T., Viitala, L., Kontturi, L.-S., Laaksonen, T., Liang, H., Vuorimaa, E., Viitala, T., Guével, X. L., Yliperttula, M. L., Murtomäki, L. S., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.028 · Cited by 141
Self-citation
Active ion transport pathways in the bovine retinal pigment epithelium.
Miller, S. S., & Edelman, J. L. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018067 · Cited by 140
Advances in the Cell Biology of Transport via the Inner Blood-Retinal Barrier: Establishment of Cell Lines and Transport Functions
Hosoya, K., & Tomi, M. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.1 · Cited by 137
VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration
Dixon, J. A., Oliver, S. C. N., Olson, J. L., & Mandava, N. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903201684 · Cited by 137
Clinical pharmacokinetics of the eye. Proctor lecture.
Mishima, S. (1981) · PubMed · Cited by 132
Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats
Merodio, M., Irache, J. M., Valamanesh, F., & Mirshahi, M. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00284-8 · Cited by 132
The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies
Herrero‐Vanrell, R., Bravo‐Osuna, I., Andrés‐Guerrero, V., Vicario‐de‐la‐Torre, M., & Molina-Martínez, I. T. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.04.002 · Cited by 130
Intraocular injection of tamoxifen‐loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis
de Kozak, Y., Andrieux, K., Villarroya, H., Klein, C., Thillaye‐Goldenberg, B., Naud, M., Garcia, E., & Couvreur, P. (2004) · European Journal of Immunology · doi:10.1002/eji.200425022 · Cited by 130
P-glycoprotein expression in human retinal pigment epithelium.
Kennedy, B. G., & Mangini, N. J. (2002) · PubMed · Cited by 130
Controlled Drug Release from an Ocular Implant: An Evaluation Using Dynamic Three-Dimensional Magnetic Resonance Imaging
Kim, H. C., Robinson, M. R., Lizak, M. J., Tansey, G., Lutz, R. J., Yuan, P., Wang, N. S., & Csaky, K. G. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0091 · Cited by 129
Quantitative Proteomics Analysis of Vitreous Humor from Diabetic Retinopathy Patients
Loukovaara, S., Nurkkala, H., Tamene, F., Gucciardo, E., Liu, X., Repo, P. E., Lehti, K., & Varjosalo, M. T. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00900 · Cited by 129
Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes
Julien, S., Biesemeier, A., Taubitz, T., & Schraermeyer, U. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-304019 · Cited by 127
Short-Term Outcomes of Aflibercept for Neovascular Age-Related Macular Degeneration in Eyes Previously Treated With Other Vascular Endothelial Growth Factor Inhibitors
Ho, V. Y., Yeh, S., Olsen, T. W., Bergstrom, C. S., Yan, J., Cribbs, B. E., & Hubbard, G. B. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.02.009 · Cited by 126

Research works printed but not linked: 7

Barza, 1982, The effects of infection and probenecid on the transport of carbenicillin from the rabbit vitreous humor. Investig. Ophthalmol, Vis. Sci., 22, 720
Gisladottir, 2009, Diffusion characteristics of vitreous humour and saline solution follow the Stokes Einstein equation. Graefe's Arch. Clin. Exp, Ophthalmol, 247, 1677
Haselton, 1996, Modulation of retinal endothelial barrier in a perfused cell-column model of the retinal microvasculature, Investig. Ophthalmol. Vis. Sci., 37, 211
Johnson, 1984, vol. 39, 791
Szebeni, 2005, Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity, Toxicology, 216, 106, 10.1016/j.tox.2005.07.023 · DOI
Szebeni, 2011, Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention, Adv. Drug Deliv. Rev., 63, 1020, 10.1016/j.addr.2011.06.017 · DOI
U.S. Food and Drug Administration, 2013, Guidance for industry: immunogenicity assessment for therapeutic protein products, Biotechnol. Law Rep., 172

Sorted by citations

Next generation antibody drugs: pursuit of the 'high-hanging fruit'
Carter, P. J., & Lazar, G. A. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.227 · Cited by 780
Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration
Kaarniranta, K., Uusitalo, H. M. T., Błasiak, J., Felszeghy, S., Kannan, R., Kauppinen, A., Salminen, A., Sinha, D., & Ferrington, D. A. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100858 · Cited by 548
Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations
Varela‐Fernández, R., Díaz-Tomé, V., Luaces-Rodríguez, A., Conde-Penedo, A., García‐Otero, X., Álvarez, A. L., Fernández‐Ferreiro, A., & Otero-Espinar, F. J. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030269 · Cited by 374
Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities
Mettu, P. S., Allingham, M. J., & Cousins, S. W. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100906 · Cited by 370
Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications
Zhang, J., Zhang, J., Zhang, J., Zhang, J., Gu, L., Luo, D., & Qiu, Q. (2022) · Cells · doi:10.3390/cells11213362 · Cited by 325

See all 693

Authors: del Amo, E. M., Rimpelä, A.-K., Heikkinen, E., Kari, O. K., Ramsay, E., Lajunen, T., Schmitt, M., Pelkonen, L., Bhattacharya, M., Richardson, D., Subrizi, A., Turunen, T., Reinisalo, M., Itkonen, J., Toropainen, E., Casteleijn, M., Kidron, H., Antopolsky, M., Vellonen, K.-S., Ruponen, M., & Urtti, A.
Affiliations: University of Helsinki (FI)
University of Eastern Finland (FI)
ORCID: Rimpelä, Anna-Kaisa
Heikkinen, Emma
Kari, Otto K.
Ramsay, Eva
Lajunen, Tatu
Pelkonen, Laura
Bhattacharya, Madhushree
Subrizi, Astrid
Reinisalo, Mika
Itkonen, Jaakko
Toropainen, Elisa
Casteleijn, Marco
Kidron, Heidi
Vellonen, Kati-Sisko
Ruponen, Marika
Urtti, Arto
Venue: Progress in Retinal and Eye Research
Publisher: Elsevier BV
Published: 2017-03
Volume: 57
Pages: 134-185
ISSN: 1350-9462 (ISSN-L)
DOI: 10.1016/j.preteyeres.2016.12.001
OpenAlex: W2567416294
Cited by: 693
References: 476
Citations by year: 2026: 68 · 2025: 96 · 2024: 76 · 2023: 92 · 2022: 74 · 2021: 94 · 2020: 81 · 2019: 59 · 2018: 34 · 2017: 18
FWCI: 3.13
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
Locations: Progress in Retinal and Eye Research (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Research Explorer (The University of Manchester) (publishedVersion, other-oa)
UEF eRepo (University of Eastern Finland) (submittedVersion)
Työväentutkimus Vuosikirja (submittedVersion)
Funders: Sigrid Juséliuksen Säätiö (64578)
Itä-Suomen Yliopisto
Academy of Finland (263573, 263615, 268868, 272597, 283721)
Tekes (637/31/2015 TEKES)
Seventh Framework Programme
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Keywords: retinal drug delivery, pharmacokinetics, intravitreal injection, systemic drug delivery, topical ocular drug delivery, targeted drug delivery, dosage, tolerability, ocular drug delivery systems
MeSH terms: Animals, Humans, Retina, Retinal Diseases, Tissue Distribution, Drug Delivery Systems, Angiogenesis Inhibitors, Intravitreal Injections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pharmacokinetic aspects of retinal drug delivery

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks